Merck
Search Within
アプリケーション
製品区分
対象分野
コンテンツの種類
コレクション
言語
facet topic

表示中 1-30 of 8576 結果
iScale siRNA
iScale siRNA are milligram and gram quantities custom siRNA duplexes manufactured to meet specialized needs for in vivo, high-throughput, and commercial projects
Next-Gen Sequencing Oligo
Next-Gen Sequencing Oligo. Product VC00101N
Commercial Use Oligo
Commercial Use Oligo. Product COMOLIGO
eLearning Courses
Chemical Safety and Regulatory Compliance Education
Pure & Simple Primers
Pure & Simple Primers. Product VC00026
Easy Oligos
Easy Oligos. Product VC00027
Scorpions UniProbe
Scorpions probes are highly sensitive, sequence-specific, bi-labeled fluorescent probe/primer hybrids designed for qPCR.
iScale Oligo
iScale Oligo. Product VC00035
MilliporeSigma Advances Bioprocessing Capabilities with Raman Technology Sensor Acquisition
MilliporeSigma Advances Bioprocessing Capabilities with Raman Technology Sensor Acquisition
MilliporeSigma Awarded Second U.S. Patent for CRISPR Gene-Editing Technology
MilliporeSigma Awarded Second U.S. Patent for CRISPR Gene-Editing Technology
MilliporeSigma Licenses Foundational CRISPR Integration Technology to Promega
MilliporeSigma Licenses Foundational CRISPR Integration Technology to Promega
MilliporeSigma Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing
MilliporeSigma Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing
MilliporeSigma’s New LANEXO™ System to Improve Scientists’ Productivity in the Lab
MilliporeSigma’s New LANEXO™ System to Improve Scientists’ Productivity in the Lab
Japan and Singapore Grant CRISPR Patents to MilliporeSigma
Japan and Singapore Grant CRISPR Patents to MilliporeSigma
MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec
MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec
MilliporeSigma Launches First Flagship Store on Alibaba’s 1688.com to Improve the Customer Experience
MilliporeSigma Launches First Flagship Store on Alibaba’s 1688.com to Improve the Customer Experience
MilliporeSigma and 10x Genomics Launch Powerful New Option for CRISPR Research
MilliporeSigma and 10x Genomics Launch Powerful New Option for CRISPR Research
MilliporeSigma’s New BrightLab™ Cloud-hosted Software Brings IoT to R&D
MilliporeSigma’s New BrightLab™ Cloud-hosted Software Brings IoT to R&D
MilliporeSigma Inaugurates New, Upgraded Onsite Industrial Water Treatment Plant
MilliporeSigma Inaugurates New, Upgraded Onsite Industrial Water Treatment Plant
MilliporeSigma Invests $20 Million in New Switzerland Laboratory
MilliporeSigma Invests $20 Million in New Switzerland Laboratory
MilliporeSigma Celebrates Topping-Out Ceremony for New Membrane Production Plant
MilliporeSigma Celebrates Topping-Out Ceremony for New Membrane Production Plant
MilliporeSigma to Manufacture Elypta’s Liquid Biopsy Kits
MilliporeSigma to Manufacture Elypta’s Liquid Biopsy Kits
MilliporeSigma Granted 20 CRISPR Patents Total Worldwide
MilliporeSigma Granted 20 CRISPR Patents Total Worldwide
MilliporeSigma and India’s Food Safety and Standards Authority Partner on Skill Development in Food Safety
MilliporeSigma and India’s Food Safety and Standards Authority Partner on Skill Development in Food Safety
MilliporeSigma Receives First U.S. Patent for Improved CRISPR Genome-Editing Method
MilliporeSigma Receives First U.S. Patent for Improved CRISPR Genome-Editing Method
MilliporeSigma Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease
MilliporeSigma Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease
MilliporeSigma Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant
MilliporeSigma Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant
MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19
MilliporeSigma and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19
MilliporeSigma Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity
MilliporeSigma Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity
MilliporeSigma Expands Cell Culture Media Production Facility in Irvine
MilliporeSigma Expands Cell Culture Media Production Facility in Irvine
1 / 286 ページ